ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Rheumatology

Top Rheumatology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JORGE ZAMORA-QUEZADA M.D.

Rheumatology

20,352

$9.2M

1885
1215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

54%
prescriptions for brand name drugs

Avg: 26%

$452
Average prescription price

Avg: $175

ROGELIO GARCIA-CAVAZOS M.D.

Rheumatology

16,885

$1.08M

719
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $175

ELVIN GARCIA M.D.

Rheumatology

16,641

$5M

1904
1309 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$300
Average prescription price

Avg: $175

KAYVAN KAMALI M.D.

Rheumatology

13,869

$1.95M

1030
638 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$140
Average prescription price

Avg: $175

JITENDRA VASANDANI MD

Rheumatology

10,314

$1.09M

674
493 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$106
Average prescription price

Avg: $175

SHAIKH ALI MD PA

Rheumatology

9,956

$1.52M

934
667 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$152
Average prescription price

Avg: $175

JANET SCHWARTZENBERG MD

Rheumatology

9,617

$782K

696
589 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 16%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$81
Average prescription price

Avg: $175

ENCARNACION RODRIGUEZ M.D.

Rheumatology

9,596

$2.25M

891
554 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 26%

$234
Average prescription price

Avg: $175

ADRIANA POP MOODY MD

Rheumatology

8,913

$1.4M

777
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $175

EUGENE NUNNERY M.D.

Rheumatology

7,367

$1.34M

950
700 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$182
Average prescription price

Avg: $175

GERALD ROSENBERG M.D.

Rheumatology

7,217

$1.32M

393
238 are 65+

27%
patients receiving schedule two controlled substances

Avg: 1%

51%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$183
Average prescription price

Avg: $175

KARL HEMPEL M.D.

Rheumatology

7,156

$648K

555
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$91
Average prescription price

Avg: $175

EUGENE MCDANALD M.D

Rheumatology

7,139

$1.08M

610
421 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$152
Average prescription price

Avg: $175

ROBERT ABRESCH M.D.

Rheumatology

6,996

$1.11M

594
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 26%

$158
Average prescription price

Avg: $175

JOSE DEL GIUDICE MD

Rheumatology

6,964

$1.26M

577
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$181
Average prescription price

Avg: $175

WILLIAM BRELSFORD MD, FACP, FACR

Rheumatology

6,587

$762K

526
367 are 65+

47%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$116
Average prescription price

Avg: $175

ANN ALEMAN WEINMANN MD

Rheumatology

6,534

$993K

440
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$152
Average prescription price

Avg: $175

NAGA BUSHAN MD

Rheumatology

6,461

$1.2M

559
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$186
Average prescription price

Avg: $175

SCOTT STEIN DOPA

Rheumatology

6,377

$1.1M

512
327 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$173
Average prescription price

Avg: $175

AGRICEL LUGO MD

Rheumatology

6,295

$1.18M

510
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 26%

$187
Average prescription price

Avg: $175

ALAN CROOCK MD

Rheumatology

6,289

$265K

431
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $175

VIJAY KUMAR MD

Rheumatology

6,173

$556K

640
481 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$90
Average prescription price

Avg: $175

CLAUDIO LEHMANN M.D.

Rheumatology

6,032

$903K

462
354 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$150
Average prescription price

Avg: $175

SAMUEL PEGRAM M.D.

Rheumatology

5,962

$701K

691
388 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

34%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$118
Average prescription price

Avg: $175

DHIMAN BASU MD

Rheumatology

5,719

$792K

386
256 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$139
Average prescription price

Avg: $175

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank